Quality of Life After Stereotactic Body Radiation therapy Versus Video-Assisted Thoracic Surgery in Early stage Non-small Cell Lung Cancer. Is there Enough Data to Make a Recommendation?
Background and aim: Health reported quality of life test (HRQOLT) in oncologic patients has become a major concern. Early stage in non-small cell lung cancer (ES-NSCLC) has two options for treatment in fragile population: Stereotactic body radiation therapy (SBRT) and Video assisted thoracic surgery (VATS). Which option should be recommended in daily clinical practice remains a challenging question. The current review is addressing this concern. Among 1256 articles, 19 met the inclusion criteria and 2034 patients were analyzed treated either with VATS or SBRT. Eleven manuscripts in SBRT, five VATS studies and three reviews were summarized in the present review. In fragile population, SBRT seems to be a valuable option of treatment with minor or no changes in HRQOLT. However, baseline quality of life status or geriatric assessment tools before treatment could be a good strategy to select appropriate population for undergoing SBRT or surgery.
Relevance for patients: In this paper, we present a systematic review where we compare the current evidence of two options for treatment in fragile population: Stereotactic body radiation therapy (SBRT) and Video assisted thoracic surgery (VATS).
[1] Vansteenkiste J, Crino L, Dooms C, Douillard JY, FaivreFinn C, Lim E, et al. 2nd ESMO Consensus Conference on Lung Cancer: Early-Stage Non-Small-Cell Lung Cancer Consensus on Diagnosis, Treatment and Follow-Up. Ann Oncol 2014;25:1462-74.
[2] Majem M, Juan O, Insa A, Reguart N, Trigo JM, Carcereny E, et al. SEOM Clinical Guidelines for the Treatment of Non-Small Cell Lung Cancer (2018). Clin Transl Oncol 2019;21:3-17.
[3] Sun B, Brooks ED, Komaki RU, Liao Z, Jeter MD, McAleer MF, et al. 7-Year Follow-Up after Stereotactic Ablative Radiotherapy for Patients with Stage I NonSmall Cell Lung Cancer: Results of a Phase 2 Clinical Trial: Outcomes After SABR for Stage I NSCLC. Cancer 2017;123:3031-9.
[4] Schnipper LE, Davidson NE, Wollins DS, Tyne C, BlayneyDW, Blum D, et al. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. J Clin Oncol 2015;33:2563-77.
[5] Chang MY, Mentzer SJ, Colson YL, Linden PA, Jaklitsch MT, Lipsitz SR, et al. Factors Predicting Poor Survival after Resection of Stage IA Non-Small Cell Lung Cancer. J Thorac Cardiovasc Surg 2007;134:850-6.
[6] SEER Stat Fact Sheets: Lung and Bronchus; 2021. Available from: https://www.seer.cancer.gov/statfacts/ html/lungb.html. [Last accessed on 2021 Jan 16].
[7] Videtic GM, Donington J, Giuliani M, Heinzerling J, Karas TZ, Kelsey CR, et al. Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol 2017;7:295-301.
[8] Lee EO, Emanuel EJ. Shared Decision Making to Improve Care and Reduce Costs. N Engl J Med 2013;368:6-8.
[9] Mokhles S, Nuyttens JJ, de Mol M, Aerts JG, Maat AP, Birim Ö, et al. Treatment Selection of Early Stage NonSmall Cell Lung Cancer: The Role of the Patient in Clinical Decision Making. BMC Cancer 2018;18:79.
[10] Donington JS, Kim YT, Tong B, Moreira AL, Bessich J, Weiss KD, et al. Progress in the Management of EarlyStage Non-Small Cell Lung Cancer in 2017. J Thorac Oncol 2018;13:767-78.
[11] Bendixen M, Jørgensen OD, Kronborg C, Andersen C, Licht PB. Postoperative Pain and Quality of Life after Lobectomy via Video-Assisted Thoracoscopic Surgery or Anterolateral Thoracotomy for Early Stage Lung Cancer: A Randomised Controlled Trial. Lancet Oncol 2016;17:836-44.
[12] Khullar OV, Rajaei MH, Force SD, Binongo JN, Lasanajak Y, Robertson S, et al. Pilot Study to Integrate Patient Reported Outcomes After Lung Cancer Operations Into the Society of Thoracic Surgeons Database. Ann Thorac Surg 2017;104:245-53.
[13] Nambu A, Onishi H, Aoki S, Tominaga L, Kuriyama K, Araya M, et al. Rib Fracture after Stereotactic Radiotherapy for Primary Lung Cancer: Prevalence, Degree of Clinical Symptoms, and Risk Factors. BMC Cancer 2013;13:68.
[14] Pompili C, Novoa N, Balduyck B, ESTS Quality of Life and Patient Safety Working Group. Clinical Evaluation of Quality of Life: A Survey among Members of European Society of Thoracic Surgeons (ESTS). Interact Cardiovasc Thorac Surg 2015;21:415-9.
[15] Damm K, Roeske N, Jacob C. Health-Related Quality of Life Questionnaires in Lung Cancer Trials: A Systematic Literature Review. Health Econ Rev 2013;3:15.
[16] Donovan EK, Swaminath A. Stereotactic Body Radiation Therapy (SBRT) in the Management of Non-Small-Cell Lung Cancer: Clinical Impact and Patient Perspectives. Lung Cancer (Auckl) 2018;9:13-23.
[17] Schwartz RM, Yip R, Flores RM, Olkin I, Taioli E, Henschke C, et al. The Impact of Resection Method and Patient Factors on Quality of Life among Stage IA NonSmall Cell Lung Cancer Surgical Patients. J Surg Oncol 2017;115:173-80.
[18] Anami K, Horie J, Hirayama Y, Yamashita N, Ito K. Changes in Exercise Tolerance and Quality of Life are Unrelated in Lung Cancer Survivors who Undergo Video-Assisted Thoracic Surgery. J Phys Ther Sci 2018;30:467-73.
[19] Avery KN, Blazeby JM, Chalmers KA, Batchelor TJ, Casali G, Internullo E, et al. Impact on Health-Related Quality of Life of Video-Assisted Thoracoscopic Surgery for Lung Cancer. Ann Surg Oncol 2020;27:1259-71.
[20] Xu GW, Xie MR, Wu HR, Xiong R, Li CW, Xu SB, et al. A Prospective Study Examining the Impact of Uniportal Video-Assisted Thoracic Surgery on the Short-Term Quality of Life in Patients with Lung Cancer. Thorac Cancer 2020;11:612-8.
[21] Schwartz RM, Alpert N, Rosenzweig K, Flores R, Taioli E. Changes in Quality of Life after Surgery or Radiotherapy in Early-Stage Lung Cancer. J Thorac Dis 2019;11:154-61.
[22] Louie AV, van Werkhoven E, Chen H, Smit EF, Paul MA, Widder J, et al. Patient Reported Outcomes Following Stereotactic Ablative Radiotherapy or Surgery for Stage IA Non-Small-Cell Lung Cancer: Results from the ROSEL Multicenter Randomized Trial. Radiother Oncol 2015;117:44-8.
[23] Jain S, Poon I, Soliman H, Keller B, Kim A, Lochray F, et al. Lung Stereotactic Body Radiation Therapy (SBRT) Delivered Over 4 or 11 Days: A Comparison of Acute Toxicity and Quality of Life. Radiother Oncol 2013;108:320-5.
[24] Wolff HB, Alberts L, Kastelijn EA, Lissenberg-Witte BI, Twisk JW, Lagerwaard FJ, et al. Differences in Longitudinal Health Utility between Stereotactic Body Radiation Therapy and Surgery in Stage I Non-Small Cell Lung Cancer. J Thorac Oncol 2018;13:689-98.
[25] Alberts L, Wolff HB, Kastelijn EA, Lagerwaard FJ, Hofman FN, Sharouni SY, et al. Patient-Reported Outcomes after the Treatment of Early Stage Non-Small-Cell Lung Cancer with Stereotactic Body Radiotherapy Compared ] with Surgery. Clin Lung Cancer 2019;20:370-7.e3.
[26] Mathieu D, Campeau MP, Bahig H, Larrivée S, Vu T, Lambert L, et al. Long-Term Quality of Life in EarlyStage Non-Small Cell Lung Cancer Patients Treated with Robotic Stereotactic Ablative Radiation Therapy. Pract Radiat Oncol 2015;5:e365-73.
[27] Lagerwaard FJ, Aaronson NK, Gundy CM, Haasbeek CJ, Slotman BJ, Senan S. Patient-Reported Quality of Life after Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer. J Thorac Oncol 2012;7:1148-54.
[28] Widder J, Postmus D, Ubbels JF, Wiegman EM, Langendijk JA. Survival and Quality of Life after Stereotactic or 3D-Conformal Radiotherapy for Inoperable Early-Stage Lung Cancer. Int J Radiat Oncol Biol Phys 2011;81:e291-7.
[29] Adebahr S, Hechtner M, Schräder N, Schimek-Jasch T, Kaier K, Duncker-Rohr V, et al. Early Impact of Pulmonary Fractionated Stereotactic Body Radiotherapy on Quality of Life: Benefit for Patients with Low Initial Scores (STRIPE Trial). J Thorac Oncol 2019;14:408-19.
[30] Osoba D, Bezjak A, Brundage M, Zee B, Tu D, Pater J, et al. Analysis and Interpretation of Health-Related Quality-of-Life Data from Clinical Trials: Basic Approach of the National Cancer Institute of Canada Clinical Trials Group. Eur J Cancer 2005;41:280-7.
[31] Nestle U, Adebahr S, Kaier K, Gkika E, SchimekJasch T, Hechtner M, et al. Quality of Life after Pulmonary Stereotactic Fractionated Radiotherapy (SBRT): Results of the Phase II STRIPE Trial. Radiother Oncol 2020;148:82-8.
[32] Rutkowski J, Szymanik M, Blok M, Kozaka J, Zaucha R. Prospective Evaluation of Anxiety, Depression and Quality of Life in Medically Inoperable Early Stage NonSmall Cell Lung Cancer Patients Treated with Stereotactic Ablative Radiotherapy. Rep Pract Oncol Radiother 2017;22:217-22.
[33] Ubels RJ, Mokhles S, Andrinopoulou ER, Braat C, van der Voort van Zyp NC, Aluwini S, et al. Quality of Life during 5 Years after Stereotactic Radiotherapy in Stage I NonSmall Cell Lung Cancer. Radiat Oncol 2015;10:98.
[34] van der Voort van Zyp NC, Prévost JB, van der Holt B, Braat C, van Klaveren RJ, Pattynama PM, et al. Quality of Life after Stereotactic Radiotherapy for Stage I NonSmall-Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2010;77:31-7.
[35] Chen H, Louie AV, Boldt RG, Rodrigues GB, Palma DA, Senan S. Quality of Life after Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer: A Systematic Review. Clin Lung Cancer 2016;17:e141-9.
[36] Yokoba M, Ichikawa T, Harada S, Naito M, Sato Y, Katagiri M. Postoperative Pulmonary Function Changes According to the Resected Lobe: A 1-Year FollowUp Study of Lobectomized Patients. J Thorac Dis 2018;10:6891-902.
[37] Wei S, Chen F, Liu R, Fu D, Wang Y, Zhang B, et al. Outcomes of Lobectomy on Pulmonary Function for Early Stage Non-Small Cell Lung Cancer (NSCLC) Patients with Chronic Obstructive Pulmonary Disease (COPD). Thorac Cancer 2020;11:1784-9.
[38] Matsumoto R, Takamori S, Yokoyama S, Hashiguchi T, Murakami D, Yoshiyama K, et al. Lung Function in the Late Postoperative Phase and Influencing Factors in Patients Undergoing Pulmonary Lobectomy. J Thorac Dis 2018;10:2916-23.
[39] Tantucci C, Modina D. Lung Function Decline in COPD. Int J Chron Obstruct Pulmon Dis 2012;7:95-9.
[40] Navarro-Martin A, Aso S, Cacicedo J, Arnaiz M, Navarro V, Rosales S, et al. Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months. J Thorac Oncol 2016;11:1101-11.
[41] M.D. Anderson Cancer Center. International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy with Surgical Resection in Stage I Non-Small Cell Lung Cancer, NCT00840749; 2009. Available from: https://www.clinicaltrials.gov/ct2/show/ nct00840749. [Last accessed on 2021 May 18].
[42] The Netherlands Organization for Health Research and Development. A Randomized Clinical Trial of Surgery Versus Radiosurgery (Stereotactic Radiotherapy) in Patients with Stage IA NSCLC Who Are Fit to Undergo Primary Resection, NCT00687986; 2008. Available from: https://www.clinicaltrials.gov/ct2/show/ nct00687986. [Last accessed on 2021 May 18].
[43] Simone CB 2nd, Dorsey JF. Additional Data in the Debate on Stage I Non-Small Cell Lung Cancer: Surgery Versus Stereotactic Ablative Radiotherapy. Ann Transl Med 2015;3:172.
[44] Deng HY, Wang YC, Ni PZ, Li G, Yang XY, Lin YD, et al. Radiotherapy, Lobectomy or Sublobar Resection? A Meta-Analysis of the Choices for Treating Stage I Non-Small-Cell Lung Cancer. Eur J Cardiothorac Surg 2017;51:203-10.
[45] Stokes WA, Rusthoven CG. Surgery vs. SBRT in Retrospective Analyses: Confounding by Operability is the Elephant in the Room. J Thorac Dis 2018;10 Suppl 17:S2007-10.
[46] Rusthoven CG, Jones BL, Kavanagh BD. Medical Operability and Inoperability Drive Survival in Retrospective Analyses Comparing Surgery and SBRT for Early-Stage Lung Cancer. J Thorac Cardiovasc Surg 2018;155:810-1.